The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 18, 2025
Filed:
Aug. 28, 2020
Applicant:
Hibercell, Inc., New York, NY (US);
Inventors:
Mark J. Mulvihill, New York, NY (US);
An-Hu Li, New York, NY (US);
Matthew David Surman, Albany, NY (US);
Assignee:
HiberCell, Inc., New York, NY (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 487/10 (2006.01); C07D 213/82 (2006.01); C07D 241/26 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 417/12 (2006.01);
U.S. Cl.
CPC ...
C07D 487/10 (2013.01); C07D 213/82 (2013.01); C07D 241/26 (2013.01); C07D 401/12 (2013.01); C07D 405/12 (2013.01); C07D 417/12 (2013.01);
Abstract
Provided herein are compounds, compositions, and methods useful for inhibiting PERK and for treating related conditions, diseases, and disorders. PERK-inhibiting compounds of Formula (I) having the following structure: are described herein. Also described herein are pharmaceutical compositions containing a compound of Formula (I) in one or more pharmaceutically acceptable carriers, diluents, or excipients, as well as methods for inhibiting a PERK enzyme in a patient or treating cancer in a patient.